Key facts
- This page summarizes Lloyd Minor's Form 4 filing for Caris Life Sciences, Inc. (CAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2026, 07:48.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.